DAWN CH Newsletters 2015
December 2015
Support desk holiday closures
Interactions with other systems
Front Screen Tallies
The dangers of copying and pasting
Windows 2012 server upgrades – access and permissions with DAWN CH
Novel Mutations Identified in Triple Negative Myeloproliferative Neoplasms
Final NICE ‘no’ for pancreatic cancer drug
Multiple Recurrent Mutations Linked to Worse Outcome in Relapsed CLL
November 2015
Support desk holiday closures
Interactions with other systems
Front Screen Tallies
The dangers of copying and pasting
Windows 2012 server upgrades – access and permissions with DAWN CH
Novel Mutations Identified in Triple Negative Myeloproliferative Neoplasms
Final NICE ‘no’ for pancreatic cancer drug
Multiple Recurrent Mutations Linked to Worse Outcome in Relapsed CLL
October 2015
Work smarter – Version 7.9.45 – 7.9.47
Improve communication How do you score toxicity?
DAWN CH enables monitoring of a wide range of haematological disorders
Vemurafenib May Be Effective in Relapsed, Refractory Hairy-cell Leukemia
Chemotherapy Protects Kidneys in LCDD
Long-term remissions achieved in first personalized cell therapy trial
September 2015
Important information for customers – Server/PC/Internal IT system upgrades and replacements
Regular backups of your DAWN CH system are essential
Boost team work with electronic referrals
DAWN CH enables monitoring of a wide range of haematological disorders
Effect of follow-up of MGUS on survival in patients with multiple myeloma
New class of leukaemia drug approved
Immune Irregularities May Increase Melanoma Risk Among Certain Non-Hodgkin’s Lymphoma Survivors
Fewer Infections, Partial Restoration of Humoral Immunity Linked With Ibrutinib Use
August 2015
Support Desk Holiday Closure
Work Smarter – Version 7.9.44
Moving Patient Appointments Forward in DAWN CH
Ofatumumab/Chemo Combo Improves PFS By Over 50% in CLL
Study Identifies Causes of Death in Myeloproliferative Neoplasms
New Drug Approvals Bring Hope, Challenges in the Treatment of Chronic Leukaemia
July 2015
Seamless integration with healthcare systems
The importance of upgrading
Regular backups of your DAWN system are essential
Arthritis drug could be used to treat blood cancer sufferers
NICE asks for more information on Gilead’s Zydelig
Myeloproliferative neoplasms increased overall mortality
June 2015
Customer Support Resources
Work Smarter – Latest Release
Paperless working – communications and referrals
Ibrutinib shows promise in CLL/SLL
Survival of patients with chronic myeloproliferative neoplasms and new primary cancers Haemochromatosis Screening
May 2015
Customer Support Documentation
Work Smarter – Latest Release, Version 7.9.42
Boost team work with electronic referrals
Good Prognosis in Chronic Leukemia Progression After Stem Cell Transplant
New blood cancer drugs for Scotland
The cellular immune system in myelomagenesis
March/April 2015
Support Desk Holiday Closures
Improve Communication – NEW SMS/Email Functionality from DAWN
Recommendations for your DAWN system: live and test
How do you score toxicity?
Doctors hail drug that can ‘turn off cancer’
New CLL drug recommended for use on NHS
Effect of follow-up of MGUS on survival in patients with multiple myeloma
February 2015
Work Smarter in 2015 – Latest Release, 7.9.40
DAWN as a disease registry for haematology disorders
The importance of backups
Microsoft 2003 server support withdrawn
Blood cancer pill offers fresh hope for thousands of leukaemia sufferers
Order of Gene Mutations May Affect Outcomes in Myeloproliferative Neoplasms
Scientists link aggressiveness of chronic lymphocytic leukaemia to genetic variability
January 2015
Work Smarter in 2015 – Latest Release 7.9.40
Demographics Interface – Best Practice
Safely backing up your database
Boost team work with electronic referrals
NICE set to recommend another leukaemia drug
Janssen launches cancer drug Imbruvica in UK
Clinical Cancer Advances in 2014: CLL Is the Winner